Ausgabe 5/2019
Inhalt (7 Artikel)
Association of lenvatinib trough plasma concentrations with lenvatinib-induced toxicities in Japanese patients with thyroid cancer
Mitsuji Nagahama, Tomoko Ozeki, Akifumi Suzuki, Kiminori Sugino, Takenori Niioka, Koichi Ito, Masatomo Miura
Individualized treatment of head neck squamous cell carcinoma patients aged 70 or older with radiotherapy alone or associated to cisplatin or cetuximab: impact of weekly radiation dose on loco-regional control
Liliana Belgioia, Almalina Bacigalupo, Francesco Missale, Stefania Vecchio, Ilaria Chiola, Serena Callegari, Elisa Verzanini, Giorgio Peretti, Renzo Corvò
In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer
Meghna M. Baruah, Neeti Sharma
Prospective assessment of taste impairment and nausea during radiotherapy for head and neck cancer
Stefania Martini, Giuseppe Carlo Iorio, Francesca Arcadipane, Francesco Olivero, Patrick Silvetti, Monica Rampino, Paolo Garzino Demo, Massimo Fasolis, Giancarlo Pecorari, Mario Airoldi, Umberto Ricardi, Pierfrancesco Franco
Neck management in head and neck squamous cell carcinomas: where do we stand?
Guillaume Klausner, Idriss Troussier, Eivind Blais, Florent Carsuzaa, Thomas Zilli, Raymond Miralbell, Francesca Caparrotti, Juliette Thariat
Interaction between phytotherapy and oral anticancer agents: prospective study and literature review
Anne-Laure Clairet, Marie Boiteux-Jurain, Elsa Curtit, Marie Jeannin, Blandine Gérard, Virginie Nerich, Samuel Limat
First experience of durable cytoreduction in chronic lymphoid leukemia with 177Lu-DOTATATE
Tijana Savovic, John O. Prior, Marie Nicod-Lalonde, Alberic Bressoud, Stéphane Roux, Niklaus Schaefer, Marie Meyer